在服用尼莫利祖马布 (Nemolizumab) 后出现多形红病例

相关实验视频

Updated: May 21, 2025

Minimal Erythema Dose MED Testing
06:24

Minimal Erythema Dose MED Testing

Published on: May 28, 2013

41.4K

Yoshihito Mima1, Tsutomu Ohtsuka2

  • 1Department of Dermatology, Tokyo Metropolitan Police Hospital, Tokyo, JPN.

Cureus
|March 19, 2025
PubMed
概括

尼莫利祖马布 (Nemolizumab) 是一种用于结节炎 (PN) 的新疗法,它可以通过改变免疫反应来触发多形红血症 (EM). 本案例报告强调了与PN患者IL-31受体A抑制相关的潜在不良事件.

关键词:
多种形状的红.介质蛋白-31 介质蛋白-31 介质蛋白没有任何的东西可以让你感动.刺痛 刺痛 刺痛 刺痛 刺痛 刺痛t 助手 1 一个助手帮助者 2 2 帮助者

更多相关视频

Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response06:31

Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response

Published on: October 3, 2019

8.5K
Author Spotlight: Non-Surgical Treatment of Melasma– Microneedling with Tranexamic Acid04:12

Author Spotlight: Non-Surgical Treatment of Melasma– Microneedling with Tranexamic Acid

Published on: January 19, 2024

752

相关概念视频

Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
3.0K